We are live on ! Find out more
AIM

Alambic Investment Management Portfolio holdings

AUM $9.12M
1-Year Est. Return 34.55%
This Fund
S&P 500
This Quarter Est. Return
-22.45%
1 Year Est. Return
+34.55%
3 Year Est. Return
+47.56%
5 Year Est. Return
+107.87%
10 Year Est. Return
AUM
$238M
AUM Growth
+$112M
Cap. Flow
+$162M
Cap. Flow %
68.24%
Top 10 Hldgs %
11.92%
Holding
433
New
159
Increased
104
Reduced
40
Closed
129

Sector Composition

Rank Sector Weight
1 Industrials 22.48%
2 Technology 19.1%
3 Consumer Discretionary 16.4%
4 Healthcare 11.8%
5 Materials 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLPC icon
126
Preformed Line Products
PLPC
$2.35B
$694K 0.29%
12,788
+8,851
+225% +$574K
VREX icon
127
Varex Imaging
VREX
$778M
$693K 0.29%
29,270
+10,189
+53% +$259K
TWI icon
128
Titan International
TWI
$460M
$690K 0.29%
147,978
+103,193
+230% +$669K
BMY icon
129
Bristol-Myers Squibb
BMY
$130B
$687K 0.29%
+13,220
New +$710K
MTOR
130
DELISTED
MERITOR, Inc.
MTOR
$680K 0.29%
40,218
+1,300
+3% +$22.2K
BCOV
131
DELISTED
Brightcove, Inc.
BCOV
$678K 0.28%
+96,367
New +$723K
LFVN icon
132
LifeVantage
LFVN
$83.8M
$658K 0.28%
+49,886
New +$597K
ERII icon
133
Energy Recovery
ERII
$399M
$654K 0.27%
97,222
+78,704
+425% +$620K
SPTN
134
DELISTED
SpartanNash
SPTN
$654K 0.27%
+38,077
New +$692K
AIR icon
135
AAR Corp
AIR
$5.84B
$650K 0.27%
17,400
+11,800
+211% +$516K
BSET icon
136
Bassett Furniture
BSET
$172M
$647K 0.27%
32,279
+12,418
+63% +$252K
APYX icon
137
Apyx Medical
APYX
$138M
$646K 0.27%
+99,722
New +$604K
CSII
138
DELISTED
Cardiovascular Systems, Inc.
CSII
$643K 0.27%
22,559
+8,922
+65% +$283K
LRN icon
139
Stride
LRN
$3.34B
$635K 0.27%
25,608
-2,700
-10% -$57.6K
ANIK icon
140
Anika Therapeutics
ANIK
$283M
$624K 0.26%
+18,559
New +$670K
BG icon
141
Bunge Global
BG
$21.5B
$620K 0.26%
+11,600
New +$716K
SAM icon
142
Boston Beer
SAM
$1.84B
$617K 0.26%
2,560
+1,385
+118% +$387K
ACTG icon
143
Acacia Research
ACTG
$456M
$615K 0.26%
206,307
-84,693
-29% -$262K
INGR icon
144
Ingredion
INGR
$6.58B
$613K 0.26%
+6,710
New +$672K
FRGI
145
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$612K 0.26%
+39,469
New +$860K
SRGA
146
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$602K 0.25%
5,423
+4,016
+285% +$523K
CSLT
147
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$597K 0.25%
274,981
+131,241
+91% +$326K
SFM icon
148
Sprouts Farmers Market
SFM
$7.69B
$588K 0.25%
+25,000
New +$651K
PRDO icon
149
Perdoceo Education
PRDO
$1.97B
$580K 0.24%
+50,800
New +$675K
VOXX
150
DELISTED
VOXX International Corporation Class A
VOXX
$579K 0.24%
146,163
-6,621
-4% -$33K

Similar funds

Alambic Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Alambic Investment Management held 433 positions worth $238M, up 88% from $126M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Alambic Investment Management deployed $162M of net new capital in Q4 2018, opening 159 new positions and adding to 104 existing holdings. Its largest new stake was Builders FirstSource: 252,247 shares worth $2.75M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Accuray, an estimated $648K trimmed.

  • Alambic Investment Management's largest Q4 2018 buy was Builders FirstSource: 252,247 shares worth $2.75M.
  • Alambic Investment Management added most to Yellow Corporation Common Stock in Q4 2018, an estimated $4.3M increase.
  • Alambic Investment Management's biggest Q4 2018 reduction was Accuray, cutting an estimated $648K.
  • Alambic Investment Management fully exited Xcerra Corporation in Q4 2018, selling an estimated $1.73M.
  • Alambic Investment Management's ten largest holdings make up 12% of its $238M portfolio in Q4 2018.
  • Alambic Investment Management opened 159 new positions and closed 129 in Q4 2018.
  • Alambic Investment Management's portfolio value rose 88% quarter-over-quarter to $238M.

Based on Alambic Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.